DataMeds AI, Inc. (MEDS) earnings
MEDS earnings moved a median of -1.97% by the close. Quarterly and annual MEDS reports and results, each read against the price at its own news timestamp. Back to the MEDS overview →
18 measured MEDS earnings events.
Where these MEDS earnings landedvs 15 measured MEDS earnings reactions
| Middle 50% of MEDS earnings reactions | -2.40% to +5.87% |
|---|---|
| Median reaction (to close) | -1.97% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 MEDS earnings events with a measured close landed between -2.40% and +5.87%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update | Press release | -2.63% | -1.97% | |
| Form 10-Q DataMeds AI, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.63% | -1.97% | |
| Form NT 10-Q DataMeds AI, Inc. For: Jun 30 | SEC filing · Form NT | -2.63% | -1.97% | |
| Form 10-Q Scienture Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Scienture Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Scienture Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q TRxADE HEALTH, INC For: Jun 30 | SEC filing · Form 10-Q | -2.90% | -7.11% | |
| TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale | Press release | -3.65% | -10.17% | |
| Form 10-Q TRxADE HEALTH, INC For: Mar 31 | SEC filing · Form 10-Q | — | +35.27% | |
| TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q | Press release | -3.94% | +13.46% | |
| Form NT 10-Q TRxADE HEALTH, INC For: Mar 31 | SEC filing · Form NT | +1.04% | -2.09% | |
| Form 10-K/A TRxADE HEALTH, INC For: Dec 31 | SEC filing · Form 10-K | — | -4.11% | |
| TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K | Press release | -3.77% | -2.71% | |
| Form 10-K TRxADE HEALTH, INC For: Dec 31 | SEC filing · Form 10-K | — | -0.46% | |
| Form NT 10-K TRxADE HEALTH, INC For: Dec 31 | SEC filing · Form NT | +0.00% | +5.07% | |
| Form 10-Q TRxADE HEALTH, INC For: Sep 30 | SEC filing · Form 10-Q | — | +4.59% | |
| TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q. | Press release | +2.93% | +7.14% | |
| Form NT 10-Q TRxADE HEALTH, INC For: Sep 30 | SEC filing · Form NT | +2.34% | +6.67% |
Keep exploring
More MEDS: analyst actions → · SEC filings → · MEDS overview →